Evidence map›Paper›PMID 34371035›Full record

ArticleJournal of molecular and cellular cardiology2021

CaMKIIδ post-translational modifications increase affinity for calmodulin inside cardiac ventricular myocytes.

Mitchell Simon, Christopher Y Ko, Robyn T Rebbeck, Sonya Baidar, Razvan L Cornea, Donald M Bers

Open access · bronzeAbstract read
In one paragraph

Article in Journal of molecular and cellular cardiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. CaCells · 2024
    Review
  10. Review
  11. Article
  12. Article
  13. Reduced O-GlcNAcylation diminishes cardiomyocyte CaJournal of molecular and cellular cardiology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Mitchell SimonDepartment of Pharmacology, University of California, Davis, CA, USA.
Christopher Y KoDepartment of Pharmacology, University of California, Davis, CA, USA.
Robyn T RebbeckDepartment of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota, Minneapolis, MN, USA.
Sonya BaidarDepartment of Pharmacology, University of California, Davis, CA, USA.
Razvan L CorneaDepartment of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota, Minneapolis, MN, USA.
Donald M BersDepartment of Pharmacology, University of California, Davis, CA, USA. Electronic address: dmbers@ucdavis.edu.
University of California, Davis · USUniversity of Minnesota · US

Funding

Project 3 (Mercola)P01HL141084 · NHLBI · STANFORD UNIVERSITY · PI Joseph C. Wu · 2019 to 2026
$21.1M
Pathophysiological Regulation of Cardiac Myocyte RyR ChannelR01HL092097 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Donald M Bers, Robyn T Rebbeck · 2010 to 2026
$9.3M
CaMKII activation and regulation in adult cardiac myocytesR01HL142282 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BERS, DONALD M, BOSSUYT, JULIE B · 2018 to 2025
$5.4M
Structural Dynamics of Cardiac Muscle Calcium ATPase RegulationR01HL139065 · NHLBI · UNIVERSITY OF MINNESOTA · PI Robyn T Rebbeck, David D Thomas · 2020 to 2026
$5.2M
Site-Directed Oxidative Modification of Muscle Protein Structural DynamicsR37AG026160 · NIA · UNIVERSITY OF MINNESOTA · PI THOMAS, DAVID D · 2011 to 2020
$4.5M
High-Throughput Screens to Discover Novel Inhibitors of Leaky RyR2 for Heart Failure TherapyR01HL138539 · NHLBI · UNIVERSITY OF MINNESOTA · PI BERS, DONALD M, CORNEA, RAZVAN LIVIU · 2018 to 2021
$3.1M
Physiological Effects of Autonomous CaMKII Activation in Cardiac MyocytesF32HL144017 · NHLBI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI KO, CHRISTOPHER · 2018 to 2019
$123k
NHLBI NIH HHS F32 HL144017NHLBI NIH HHS P01 HL141084NHLBI NIH HHS R01 HL092097NHLBI NIH HHS R01 HL138539NHLBI NIH HHS R01 HL139065NHLBI NIH HHS R01 HL142282NIA NIH HHS R37 AG026160
6 · The paper itself

Abstract

Persistent over-activation of CaMKII (Calcium/Calmodulin-dependent protein Kinase II) in the heart is implicated in arrhythmias, heart failure, pathological remodeling, and other cardiovascular diseases. Several post-translational modifications (PTMs)-including autophosphorylation, oxidation, S-nitrosylation, and O-GlcNAcylation-have been shown to trap CaMKII in an autonomously active state. The molecular mechanisms by which these PTMs regulate calmodulin (CaM) binding to CaMKIIδ-the primary cardiac isoform-has not been well-studied particularly in its native myocyte environment. Typically, CaMKII activates upon Ca-CaM binding during locally elevated [Ca]

Indexed as

AnimalsCalcium-Calmodulin-Dependent Protein Kinase Type 2CalmodulinFluorescenceFluorescence Resonance Energy TransferGreen Fluorescent ProteinsHeart VentriclesMaleMyocytes, CardiacPhosphorylationProtein Processing, Post-TranslationalRabbitsCalcium-Calmodulin-Dependent Protein Kinase Type 2CalmodulinGreen Fluorescent ProteinsCalciumCalmodulinCaMKIICardiac myocytePost-translational modifications

Identifiers

PMID34371035
PMCPMC8716136
OpenAlexW3191978882

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.